D Raich-Regue
Overview
Explore the profile of D Raich-Regue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alemany A, Perez-Zsolt D, Raich-Regue D, Munoz-Basagoiti J, Ouchi D, Laporte-Villar C, et al.
J Dent Res
. 2022 Jun;
101(12):1450-1456.
PMID: 35727681
The airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via respiratory fluids and droplets suggests that mouthwashes containing substances with virucidal activity can help reduce viral spread. We...
2.
Munoz-Basagoiti J, Perez-Zsolt D, Leon R, Blanc V, Raich-Regue D, Cano-Sarabia M, et al.
J Dent Res
. 2021 Jul;
100(11):1265-1272.
PMID: 34282982
Oral mouthwashes decrease the infectivity of several respiratory viruses including SARS-CoV-2. However, the precise agents with antiviral activity in these oral rinses and their exact mechanism of action remain unknown....
3.
Ezzelarab M, Raich-Regue D, Lu L, Zahorchak A, Perez-Gutierrez A, Humar A, et al.
Am J Transplant
. 2016 Dec;
17(6):1476-1489.
PMID: 28009481
Systemic administration of autologous regulatory dendritic cells (DCreg; unpulsed or pulsed with donor antigen [Ag]), prolongs allograft survival and promotes transplant tolerance in rodents. Here, we demonstrate that nonhuman primate...
4.
Rosborough B, Raich-Regue D, Liu Q, Venkataramanan R, Turnquist H, Thomson A
Am J Transplant
. 2014 Oct;
14(9):2173-80.
PMID: 25307040
The mechanistic/mammalian target of rapamycin (mTOR) is inhibited clinically to suppress T cell function and prevent allograft rejection. mTOR is the kinase subunit of two mTOR-containing complexes, mTOR complex (mTORC)...
5.
Naranjo-Gomez M, Raich-Regue D, Onate C, Grau-Lopez L, Ramo-Tello C, Pujol-Borrell R, et al.
J Transl Med
. 2011 Jun;
9:89.
PMID: 21658226
Background: The use of tolerogenic DCs is a promising therapeutic strategy for transplantation and autoimmune disorders. Immunomodulatory DCs are primarily generated from monocytes (MDDCs) for in vitro experiments following protocols...